

A provider's guide to helping patients save on Prempro 0.625/2.5 28 Day, including manufacturer programs, coupons, generics, and PAPs.
Cost is one of the most common reasons patients don't fill — or stop taking — their hormone replacement therapy. As a provider prescribing Prempro 0.625/2.5 28 Day (conjugated estrogens 0.625 mg / medroxyprogesterone acetate 2.5 mg), you're in a unique position to help your patients navigate the financial side of their treatment before it becomes a barrier to adherence.
This guide covers what patients are actually paying for Prempro in 2026, the savings programs available, and how to integrate cost conversations into your clinical workflow.
The cost of Prempro 0.625/2.5 28 Day varies significantly based on insurance status and whether the patient receives brand or generic:
| Version | Estimated Cash Price (28 tablets) |
|---|---|
| Brand-name Prempro | $180 – $280 |
| Generic (conjugated estrogens/MPA) | $45 – $120 |
| Generic with discount card | $30 – $70 |
For insured patients, Prempro generics typically fall on Tier 1 (preferred generic) with copays in the $5-$25 range. Brand-name Prempro usually sits on Tier 2 (preferred brand) with higher copays. Some Medicare Part D plans may require step therapy through lower-dose formulations first.
The patients most affected by cost are those who are uninsured, underinsured, in the Medicare coverage gap ("donut hole"), or on high-deductible health plans where they're paying full price until the deductible is met.
Pfizer, which manufactures brand-name Prempro (originally through Wyeth), offers the Pfizer RxPathways program. This is an umbrella program that connects patients to multiple forms of assistance:
Key details for your practice:
Direct patients or your staff to pfizerrxpathways.com or call 1-844-989-7284.
Several nonprofit organizations maintain databases of patient assistance programs that may cover Prempro or its generic:
For patients who don't qualify for manufacturer assistance or who are filling the generic version, pharmacy discount cards can provide significant savings. These are free to use and accepted at most retail pharmacies:
Important notes for providers:
The most impactful cost-saving measure for most patients is simply prescribing the generic. Conjugated estrogens/medroxyprogesterone acetate 0.625/2.5 mg is therapeutically equivalent to brand-name Prempro and costs a fraction of the price.
When writing prescriptions:
For patients who can't find Prempro or its generic at all, therapeutic alternatives include Activella (estradiol/norethindrone acetate), Bijuva (estradiol/progesterone), or Angeliq (drospirenone/estradiol). For a clinical comparison, see our provider guide on managing the Prempro shortage.
Many patients won't bring up cost concerns on their own — either because they're embarrassed or because they don't realize there are options. Here are practical ways to address this proactively:
For more provider-focused resources on managing Prempro for your patients, visit medfinder.com/providers. You can also read our guides on helping patients find Prempro in stock and navigating the Prempro shortage as a prescriber.
Medication cost shouldn't determine whether your patients get the menopause symptom relief they need. By defaulting to generics, proactively discussing cost, and connecting patients to savings programs, you can significantly improve adherence and outcomes.
The tools are available — manufacturer programs, discount cards, patient assistance, and generic alternatives. The key is building cost awareness into your prescribing workflow so it becomes routine rather than reactive.
Your patients may not ask for help with medication costs. But when you offer it, the impact on their health — and their trust in you — is significant.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.